| Dr Leticia Maria Perez Miranda, | |
|
2925 Aventura Blvd Ste 300, Aventura, FL 33180-3109 | |
| (305) 936-1002 | |
| Not Available |
| Full Name | Dr Leticia Maria Perez Miranda |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2925 Aventura Blvd Ste 300, Aventura, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548787872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Secondary |
| 103TC0700X | Psychologist - Clinical | PY10551 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leticia Maria Perez Miranda, 888 Brickell Key Dr Apt 2302, Miami, FL 33131-2670 Ph: (785) 969-8734 | Dr Leticia Maria Perez Miranda, 2925 Aventura Blvd Ste 300, Aventura, FL 33180-3109 Ph: (305) 936-1002 |
News Archive
Patients with cancer face a serious dilemma during the COVID-19 pandemic, as staying at home could increase their risk of cancer progression, while visiting the hospital for treatment could increase their risk of becoming infected with the virus that causes COVID-19.
The Alzheimer's Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $170,750 to ADispell Inc. to develop small molecule drugs designed to halt the progression of cognition loss that occurs with Alzheimer's Disease.
Diabetes has become the leading cause of death in Mexico and the third-leading cause of death among those living along the U.S. side of the border, health officials from the United States and Mexico said today in presenting the results of a new study coordinated by the Pan American Health Organization (PAHO).
Genzyme Corporation reported today that four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial continued to show durable reductions in relapse rate and sustained accumulation of disability three years after the majority of patients received their last course of the investigational compound alemtuzumab.
Two types of guidance molecules, the attractive and the repulsive, direct the growth of nerve cells to the actual target. The designation of these molecules also describes the exclusive function that was previously attributed to them, namely to show the growing nerve fibers the way. The fundamentally new approach to the research of Prof. Dr. Schwab and his team at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) is the realization that these guidance molecules have an additional hitherto unknown role in the immune system.
› Verified 8 days ago
Dr. Dovid Kirzner, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17501 Biscayne Blvd Ste 450, Aventura, FL 33160 Phone: 305-494-1850 | |
Dr. Mary Kollias-greber, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2875 Ne 191st St Ste 500, Aventura, FL 33180 Phone: 954-963-5858 | |
Dr. Brittany Grabois Schuman, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 304, Aventura, FL 33180 Phone: 305-528-3031 | |
Joanne Feuerman, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 304, Aventura, FL 33180 Phone: 305-932-5500 Fax: 305-935-0466 | |
Dr. Carla Bejar Vinikoor, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 18999 Biscayne Blvd, Suite 200, Aventura, FL 33180 Phone: 305-933-9820 | |
Heather Rebecca Malkoff, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20155 Ne 38th Ct, #702, Aventura, FL 33180 Phone: 305-332-8500 | |
Dr. Laura Ellen Grashow, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19022 Ne 29th Ave, Aventura, FL 33180 Phone: 305-936-1002 Fax: 305-936-1022 |